Associate Professor Merran Govendir
BVSc (Hons I), PhD, MACVSc, MEd(Higher Education), fHERDSA
Associate Professor, Veterinary Pharmacology Associate Dean of Postgraduate Studies
B14 - Mcmaster Building
The University of Sydney
| Telephone | +61 2 9351 5442 |
| Fax | +61 2 9351 3056 |
|
|
Biographical details
Associate Professor Merran Govendir has focused on conducting clinical projects that have direct relevance to improving animal health. Her recent work has concentrated on clinical pharmacology. She was first investigator to publish a clinical trial in epileptic dogs to ascertain whether the human anticonvulsant drug gabapentin, reduced seizure activity. She was a member of an anaesthesia unit which was the first to publish a clinical trial using the agent sevoflurane in cats and ferrets, establishing sevoflurane as a new and useful agent for fast general anaesthetic inductions in small animals. Her most recent publications involved quantification of the development in resistance of common feline and canine bacterial pathogens to the fluoroquinolone therapeutic drugs and reporting on the susceptibility of Rapidly Growing Mycobacteria spp. (that cause skin diseases in cats and dogs) to the human fluoroquinolone moxifloxacin and the new veterinary registered fluoroquinolone pradofloxacin.
Due to her ability assay concentrations of antibiotic concentrations in biological fluids she was invited to join the Faculty group investigation the treatment of chlamydiosis and cryptococcosis in koalas. With her PhD students, she has found that many drugs given to koalas at the recommended dose rate and dosing frequency are not reaching therapeutic concentrations. She hypothesises that the koala has poor oral drug absorption and that the koala uses it very active liver enzymes (required to detoxify their very toxic Eucalypt diet) to rapidly eliminate many drugs. Preliminary studies also indicate that koalas have very poor oral drug absorption from the gastrointestinal tract. This research will ultimately result in her group making recommendations to improve the dose rates and dosage frequencies of drugs used in koalas.
Research interests
Veterinary pharmacology Histology Anaesthesia
Teaching and supervision
Veterinary Pharmacology & Toxicology Aspects of Pharmacy Practice for veterinarians
Selected grants
2012
- Optimising a commercial enzyme immunoassay to detect prostaglandin E2 in possum and koala plasma to determine the efficacy of nonsteroidal drugs in these species; Govendir M; Whitehead Bequest in Wildlife Welfare/Faculty of Veterinary Science Bequest.
- Biological variation of feline plasma biochemistry analytes; Govendir M; Deans Discretion Funds/Faculty of Veterinary Science Bequest.
2011
- Investigation into 'P-glycoprotein' efflux pumps expression and density in the gastrointestinal tract of koalas; Govendir M; Winifred Scott Foundation/Research Support.
2010
- Investigation into the significance of biomarkers in koala blood, as detected by liquid chromatography, to identify infectious disease and response to treatment; Govendir M; DVC Research/Thompson Fellowships.
- Oral absorption and deposition of xenobiotics in the koala; Govendir M; WP Richards Award in Veterinary Pathology/Faculty of Veterinary Science Bequest.
- Comparison of veterinary in-house biochemistry analysers with feline plasma samples; Govendir M; Dorothy Minchin Bequest/Faculty of Veterinary Science Bequest.
2008
- Sponsorship of the Koala Project - testing the efficacy of Metacam (meloxicam) in koalas; Govendir M, Johnson L; Boehringer Ingelheim/Research Support.
- investigated the significance of hypertriglyceridaemia in epileptic dogs medicated daily with phenobarbitone; Govendir M; J.M. and J.R Stewart Legacy/Faculty of Veterinary Science Bequest.
- the role of hypertriglyceridaemia in epileptic dogs medicated with phenobarbitone and potassium bromide; Govendir M; Thea Jean Schnakenberg /Faculty of Veterinary Science Bequest.
2007
- Investigation into gastrointestinal absorption of xenobiotics by the koala; Krockenberger M, Hemsley S, Higgins D, Canfield P, Malik (Krochmalik) R, Govendir M; Hermon Slade Foundation/Research Grants.
- Long term use of phenobarbitone in canine idiopathic epilepsy (part II); Govendir M; Canine Research foundation/Research Grants.
- Investigation into susceptibility of selected canine bacterial pathogens to newer antimicrobial agents; Govendir M; J.M. and J.R Stewart Legacy/Faculty of Veterinary Science Bequest.
- Postgraduate Education in Animal Breeding Management; Forsyth H, Govendir M; Meat and Livestock Australia Ltd/Research and Development Grant.
- Investigation into susceptibility of selected canine bacterial pathogens to newer antimicrobial agents; Govendir M; Thea Jean Schnakenberg /Faculty of Veterinary Science Bequest.
2006
- Investigation into systematic differences in serum cholesterol, lipoprotein, triglyceride and other serum analytes in dog breeds prone to idiopathic epilepsy; Govendir M; Waltham Foundation/Waltham Foundation Research Grants Program.
- Susceptibilities of canine and feline bacterial pathogens to fluroquinolones and other selected antimicrobial agents; Govendir M; Australian Companion Animal Health Foundation/Research Grants Program.
2005
- Prevention and treatment of chlamydiosis and cryptococcosis in koalas; Krockenberger M, Canfield P, Govendir M, Hemsley S, Malik (Krochmalik) R; Australian Research Council (ARC)/Linkage.
- Investigation into the long-term use of phenobarbitone in dogs with idiopathic epilepsy; Govendir M; Canine Research foundation/Grants.
2003
- Improving therapeutic control os seizures in dogs; Govendir M; Canine Research foundation/Research Grants.
Selected publications
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|